These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8302762)

  • 1. Influence of skin irritants on percutaneous absorption.
    Nangia A; Camel E; Berner B; Maibach H
    Pharm Res; 1993 Dec; 10(12):1756-9. PubMed ID: 8302762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dissociation constants (pKa) of basic permeants are associated with in vivo skin irritation in man.
    Nangia A; Andersen PH; Berner B; Maibach HI
    Contact Dermatitis; 1996 Apr; 34(4):237-42. PubMed ID: 8730159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritants and Skin Barrier Function.
    Angelova-Fischer I
    Curr Probl Dermatol; 2016; 49():80-9. PubMed ID: 26844900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium lauryl sulfate-induced skin irritation on in vitro percutaneous absorption of four drugs.
    Wilhelm KP; Surber C; Maibach HI
    J Invest Dermatol; 1991 Jun; 96(6):963-7. PubMed ID: 1828478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of detergent-induced irritant skin reactions by visual scoring and transepidermal water loss measurement.
    Tupker RA; Pinnagoda J; Coenraads PJ; Nater JP
    Dermatol Clin; 1990 Jan; 8(1):33-5. PubMed ID: 2302862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal enzymes: in vivo human skin irritation.
    Andersen PH; Bucher AP; Saeed I; Lee PC; Davis JA; Maibach HI
    Contact Dermatitis; 1994 Mar; 30(3):152-8. PubMed ID: 8187514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of primary skin irritants in vitro in a cytotoxicity model: comparison with in vivo human irritation tests.
    Wilhelm KP; Böttjer B; Siegers CP
    Br J Dermatol; 2001 Nov; 145(5):709-15. PubMed ID: 11736893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers.
    Godwin DA; Michniak BB
    Drug Dev Ind Pharm; 1999 Aug; 25(8):905-15. PubMed ID: 10434134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant-induced skin irritation and skin repair: evaluation of a cumulative human irritation model by noninvasive techniques.
    Wilhelm KP; Freitag G; Wolff HH
    J Am Acad Dermatol; 1994 Dec; 31(6):981-7. PubMed ID: 7962781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O/W emulsions compromise the stratum corneum barrier and improve drug penetration.
    Gloor M; Hauth A; Gehring W
    Pharmazie; 2003 Oct; 58(10):709-15. PubMed ID: 14609282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of barrier disruption by acetone treatment on the permeability of compounds with various lipophilicities: implications for the permeability of compromised skin.
    Tsai JC; Sheu HM; Hung PL; Cheng CL
    J Pharm Sci; 2001 Sep; 90(9):1242-54. PubMed ID: 11745777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sodium lauryl sulfate (SLS) on in vitro percutaneous penetration of water, hydrocortisone and nickel.
    Frankild S; Andersen KE; Nielsen GD
    Contact Dermatitis; 1995 Jun; 32(6):338-45. PubMed ID: 7554880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sodium lauryl sulfate-induced skin irritation on in vivo percutaneous penetration of four drugs.
    Wilhelm KP; Surber C; Maibach HI
    J Invest Dermatol; 1991 Nov; 97(5):927-32. PubMed ID: 1833470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
    Shah DK; Khandavilli S; Panchagnula R
    Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential oils from sweet basil (Ocimum basilicum) as novel enhancers to accelerate transdermal drug delivery.
    Fang JY; Leu YL; Hwang TL; Cheng HC
    Biol Pharm Bull; 2004 Nov; 27(11):1819-25. PubMed ID: 15516730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capsaicin and nonivamide as novel skin permeation enhancers for indomethacin.
    Fang JY; Fang CL; Hong CT; Chen HY; Lin TY; Wei HM
    Eur J Pharm Sci; 2001 Jan; 12(3):195-203. PubMed ID: 11113638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of impedance response patterns to histological findings in irritant skin reactions induced by various surfactants.
    Nicander I; Ollmar S; Eek A; Lundh Rozell B; Emtestam L
    Br J Dermatol; 1996 Feb; 134(2):221-8. PubMed ID: 8746333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin barrier integrity and natural moisturising factor levels after cumulative dermal exposure to alkaline agents in atopic dermatitis.
    Angelova-Fischer I; Dapic I; Hoek AK; Jakasa I; Fischer TW; Zillikens D; Kezic S
    Acta Derm Venereol; 2014 Nov; 94(6):640-4. PubMed ID: 24531413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant-induced skin irritation and skin repair. Evaluation of the acute human irritation model by noninvasive techniques.
    Wilhelm KP; Freitag G; Wolff HH
    J Am Acad Dermatol; 1994 Jun; 30(6):944-9. PubMed ID: 8188884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crude drug (zingiberaceae) enhancement of percutaneous absorption of indomethacin: in vitro and in vivo permeation.
    Huang YB; Hsu LR; Wu PC; Ko HM; Tsai YH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Jul; 9(7):392-400. PubMed ID: 8366543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.